ALLR
Allarity Therapeutics
ALLR
ALLR
5 hedge funds and large institutions have $122K invested in Allarity Therapeutics in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$78.7K |
| 2 |
Goldman Sachs
New York
|
$24.1K |
| 3 |
Citigroup
New York
|
$14.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
$4.99K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$26 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
1
Stonepine Capital Management
Bend,
Oregon
| $78.7K | +$78.7K | +67,289 | New |
|
|
2
Goldman Sachs
New York
| $24.1K | +$24.1K | +20,616 | New |
|
|
3
Citigroup
New York
| $14.4K | +$14.4K | +12,294 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $4.99K | +$1.01K | +863 | +25% |
|
|
5
Bank of America
Charlotte,
North Carolina
| $26 | +$13 | +11 | +100% |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$38.9K | -18,452 | Closed |
|